Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06429397
Status:
RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-04-08
Brief Title:
First-line Anlotinib Combined With Penpulimab for Advanced Pheochromocytoma A Single-arm Multicenter Prospective Phase II Study
Sponsor:
Sun Yat-sen University
Organization:
Sun Yat-sen University
Organization Data
Organization:
Sun Yat-sen University
Class:
OTHER
Study ID:
2023-FXY-304
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sun Yat-sen University
Lead Sponsor Class:
OTHER
Responsible Party:
ZHOU FANGJIAN
Responsible Party Title:
Sun Yat-sen University Cancer Center
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Sun Yat-sen University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co Ltd | INDUSTRY |